Global Tumor NGS Detection Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Tumor NGS Detection Market 2023 by Company, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global Tumor NGS Detection market size was valued at USD 1888.1 million in 2022 and is forecast to a readjusted size of USD 5059.4 million by 2029 with a CAGR of 15.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The main purpose of NGS is to discover clinically treatable genetic variants and guide patient treatment.

This report is a detailed and comprehensive analysis for global Tumor NGS Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Tumor NGS Detection market size and forecasts, in consumption value ($ Million), 2018-2029

Global Tumor NGS Detection market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Tumor NGS Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Tumor NGS Detection market shares of main players, in revenue ($ Million), 2018-2023.

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Tumor NGS Detection

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace.

This report profiles key players in the global Tumor NGS Detection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent, Thermo Fisher Scientific, BGI Group, Roche Foundation Medicine and Sinopharm Group, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Tumor NGS Detection market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Medical Equipment
Consumables

Market segment by Application
Companion Diagnostics
Early Cancer Screening
Drug Discovery
Other

Market segment by players, this report covers
Agilent
Thermo Fisher Scientific
BGI Group
Roche Foundation Medicine
Sinopharm Group
Fosunpharma
Novogene
Geneseeq
AmoyDx
Burning Rock Medicine
Perkin Elmer
Qiagen NV
Partek
Illumina Inc.
Pacific Biosciences of California Inc.
Life Technologies Corporation
GTH.O
Paradigm Diagnostics
Oxford Nanopore Technologies Ltd.
Eurofins Scientific S.E.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Tumor NGS Detection product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Tumor NGS Detection, with revenue, gross margin and global market share of Tumor NGS Detection from 2018 to 2023.

Chapter 3, the Tumor NGS Detection competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Tumor NGS Detection market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Tumor NGS Detection.

Chapter 13, to describe Tumor NGS Detection research findings and conclusion.